Clinical Aspects and Management of Levodopa-Induced Dyskinesia
In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa do...
Main Authors: | Nicola Tambasco, Simone Simoni, Erica Marsili, Elisa Sacchini, Donatella Murasecco, Gabriela Cardaioli, Aroldo Rossi, Paolo Calabresi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2012/745947 |
Similar Items
-
Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
by: Paolo Calabresi, et al.
Published: (2019-12-01) -
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias
by: Jennifer Stanic, et al.
Published: (2017-12-01) -
Dysregulation of BET proteins in levodopa-induced dyskinesia
by: David A. Figge, et al.
Published: (2017-06-01) -
Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
by: Chang-Qing Zheng, et al.
Published: (2021-06-01) -
Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
by: J. Guridi, et al.
Published: (2012-01-01)